Latest news with #Smithfield
Yahoo
29-05-2025
- Business
- Yahoo
Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology
Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million to Drive Innovation, Clinical Expansion, and Global Market Growth SMITHFIELD, R.I., May 29, 2025 /CNW/ -- Acclaro Medical, a pioneering medical technology company focused on developing cutting-edge solutions that improve patient care and redefine medical practices, proudly announces the successful completion of its Series B funding round. Led by Accelmed Partners with participation by existing investor 3E Bioventures Capital, the combined funding of $23 million marks a pivotal milestone in the company's journey to fulfill unmet aesthetic needs through its innovative 2910 nm fiber laser solution and other disruptive technologies. This capital infusion will help Acclaro accelerate the growth of its flagship products, UltraClear® and AuraLux™ and expedite global market expansion while advancing development of new trailblazing products in its pipeline. Acclaro Medical's UltraClear fiber laser is recognized by leading aesthetic professionals as a breakthrough in Total Skin Health that treats multiple skin layers to help reverse the signs of aging and gravity. The first of its kind 2910 nm cold ablative fiber laser, powered by proprietary 3DIntelliPulse™ technology, delivers: Unparalleled clinical efficacy Superior patient experiences Unmatched versatility Significantly improved safety for all skin types, including previously high-risk skin-of-color patients. Its precision-engineered capabilities make it the ideal choice for practitioners seeking transformative results with minimal downtime, reduced patient discomfort and speedy healing. Complementing UltraClear, the AuraLux laser leverages the same exclusive Cool Pulse™ technology and broadens accessibility for aesthetic providers and their patients while maintaining Acclaro's hallmark quality. "Securing this Series B investment is a powerful testament to our unstoppable team and the tremendous progress that Acclaro has made in a very short period of time," said Acclaro Medical CEO and Co-founder Helen Fang. "This funding empowers us to continue our strong growth and realize our vision of improving the quality of life for people of all skin colors and all ages worldwide." Shlomo Assa, President and co-founder of Acclaro Medical, noted: "We are thrilled to have the support of Accelmed as we expand our global and domestic footprint. This Series B funding is a strong vote of confidence in our mission to bring UltraClear and AuraLux to more people pursuing anti-aging solutions for healthier and younger-looking skin. It greatly enables us to accelerate product development, expand our team, and reach more customers globally – And we're just getting started!" The Series B funding will allow Acclaro Medical to leverage decades of Accelmed's operational and financial expertise, alongside 3E Bioventures' disciplined efficiency. Acclaro Medical is poised to execute its strategic plans and realize its vision of revolutionizing the aesthetic industry. These efforts will further cement the company's position as a leader in providing innovative, patient-centered skin health solutions. "Acclaro's unique cold laser fiber technology constitutes a game changer in laser aesthetics with the possibility for aesthetic practices to safely treat all skin types for all major indications using only one device," stated Daniel Cohen, Accelmed's venture partner with extensive experience leading successful Medtech & Biotech investments over the last 20 years. "Accelmed Partners is thrilled to lead this round of financing and accompany Acclaro' s management in this fantastic journey." About Acclaro Medical Founded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating and bringing to market game-changing solutions to address today's unmet medical, aesthetic and surgical practice needs. With a relentless commitment to innovation and a team of dedicated professionals, Acclaro Medical continues to push the boundaries and drive positive change in the aesthetic medical industry. Its proprietary 3DMIRACL™ and Laser Coring™ skin rejuvenation treatments are valued for offering unrivaled aesthetic results complemented by high patient comfort, rapid healing and utmost safety across all skin types. For more information, please visit About Accelmed Partners Accelmed, a leader in healthcare technology investing, is renowned for its private equity approach to a sector traditionally dominated by venture and early-stage growth firms. Its team of experienced industry veterans and company builders work closely as a trusted partner with portfolio management to improve operations, upgrade product portfolios, and strengthen commercial organizations. Accelmed's support and resources are designed to help portfolio companies like Acclaro Medical elevate its technology and achieve enduring success. The investment firm currently manages over $630 million of equity capital. For more information, please visit Media Contact:Nadine ToskTosk Communications for Acclaro Medicalnadinepr@ 504.453.8344 View original content to download multimedia: SOURCE Acclaro Medical Corporation View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
RNZ News
26-05-2025
- Business
- RNZ News
Former Timaru meatworks site sold for undisclosed amount
Photo: RNZ / Nate McKinnon The former Smithfield meat processing plant site in Timaru has been sold, but Alliance Group says the price paid for the land remains a secret. Six hundred meatworkers lost their jobs last year when the farmer-owned red meat cooperative announced it would close the 139-year-old site, which it had owned since 1989. Alliance chief executive Willie Wiese said there was significant interest in the 32-hectare site. "Smithfield has been a well-known part of the Timaru landscape for nearly 140 years. While this marks the end of an era, we're pleased to have concluded the sale and to enable new investment in the site." He confirmed it had now sold, though the price and the purchaser are confidential. Alliance Group reported a loss of $95.8m after tax for the year ended September in its 2024 annual report which included the one-off charge of $51.3m to cover the redundancies and closure of the Smithfield site. Declining sheep processing numbers as a result of land-use change was credited as one of the primary reasons for the site's closure. This had resulted in surplus capacity in its plant network. Alliance Group has six processing plants across the country, including four in the South Island. Sign up for Ngā Pitopito Kōrero, a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
The Guardian
24-05-2025
- Business
- The Guardian
‘We trusted them': East End fishmongers take on the City to save ancient markets
It is a mismatched contest: a handful of east London fishmongers taking on the phenomenally wealthy City of London Corporation. But the market traders and a food poverty charity have teamed up to battle City of London Corporation over its plans to close the capital's ancient fish and meat markets for good. The corporation announced the permanent closure of London's historic Smithfield meat market and Billingsgate fish market in late 2024, when it pulled the plug on a planned £1bn relocation to a new sitein the east of the capital at Dagenham. The decision means the end of centuries of meat and fish trading in the capital. Three fishmongers from Ridley Road market in Hackney say they depend on Billingsgate for their business and will go bust if it closes down. Along with their spokesperson Alicia Weston, the founder of Bags of Taste, which teaches cooking skills to people living in poverty, they are fighting to stop parliament from rubber stamping the markets' closure. The corporation, the governing body that runs London's Square Mile, is the owner and operator of both sites, but is not permitted to close down the markets independently. A quirk of their long and storied pasts, the markets were established by acts of parliament that fix them to the existing sites. This means they can only be closed when parliament passes a private bill, repealing the legislation and allowing the land to be used for other purposes. The markets have been granted a stay of execution until 2028. In the meantime, the corporation has said it is offering compensation to Smithfield and Billingsgate traders and is helping them find new locations, but is no longer planning to build a joint replacement site. Fishmongers Waheed Aslam, Zafar Iqbal and Mohammed Amjad Choudry have objected to the bill, and they say they have the support of a small group of MPs who are opposed to the closure. The Mediterranean fish shop on Ridley Road was started 30 years ago by Aslam's father. Aslam and his business partner Aras Swara, visit Billingsgate market, the UK's largest inland fish market, early in the morning, five days a week, to choose fresh sea bream, snapper, salmon and coley for the shop. 'At the market we can choose what we buy, if there's no market, those who are selling will have a monopoly,' said Aslam. 'If there is no Billingsgate, we can't get all this variety,' added Swara, gesturing to a chest freezer containing 13 different types of frozen prawns. Aslam has previously tried buying from wholesalers, but said he was not able to buy the required quantity of fish, or was disappointed by the quality. 'We supply quite a few restaurants around the area, and it would affect them too if the market closes,' he added, as his two employees gutted and cleaned sea bass ordered by a local Caribbean restaurant. The history of a food market around Smithfield – close to Farringdon train station – goes back more than 800 years. The London Museum is in the process of moving to part of the site, which is intended to become a cultural development. Billingsgate, which was moved in 1982 from a City location by the river to a building near the Canary Wharf financial district, has been earmarked for housing. The volumes of meat and fish traded at Smithfield and Billingsgate have fallen significantly since their peak around the turn of the 20th century amid the rise of supermarkets, according to an independent report on the importance of food markets commissioned by the corporation after its decision not to build the Dagenham site. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion Despite this, the report found that Smithfield and Billingsgate 'play a vital role in supporting independent retailers, such as butchers and fishmongers' and estimated Billingsgate still accounts for 9%-11% of fish consumption in London and the south-east. The corporation scrapped plans to relocate both markets, along with the New Spitalfields fruit and vegetable market, to a purpose-built complex at Dagenham Dock, saying inflation and rising construction costs had made the project unaffordable. The corporation manages assets worth billions of pounds, and collects £1.3bn in business rates annually, although it passes most of this to central government. The fishmongers and Weston are calling on the corporation to find an alternative location for the markets. 'We trusted them and believed it was going to open in Dagenham, but they broke that trust,' said Weston. 'There are unintended consequences of the closure.' A spokesperson for the City of London Corporation said the authority is 'actively supporting the traders at Billingsgate and Smithfield to find new sites for their wholesale activity within the M25. This includes practical support, such as brokering discussions with landowners and developers, and assisting a smooth transition'. 'We just want assurance that an alternative market will be opened,' said Aslam. 'We have a livelihood on the line. We are at the bottom of the chain and have not been given much thought about.'
Irish Times
19-05-2025
- Business
- Irish Times
‘Ireland's answer to Hollows & Fentimans': The father-daughter team behind Zingibeer are chasing Gen Z drinkers
Founded by a father and daughter team in 2021, Smithfield -based ginger beer brand Zingibeer topped the €500,000 turnover mark for the first time last year, despite a challenging period which saw them forced to rebuild their distribution model. 'We want to be Ireland's answer to Hollows and Fentimans,' co-founder Rachel Byrne told The Irish Times. A former banker with AIB, she said the brand's ginger beer is 'very, very popular amongst students.' The company has sought to stand out from the pack by targeting Generation Z (born between 1997 and 2012) as their main customer demographic, securing strategic placements in Dublin bars frequented by college students. 'We are in all the student bars, we are in UCD, in DCU, we are in the Pav in Trinity.' And research showing that young people now are drinking less alcohol than in previous generations doesn't concern Ms Byrne; 'I get the sense that young people now are looking for a little bit more quality over quantity'. READ MORE 'Young people are more considered in their spend. 'What am I actually buying? Who is making this product? What's actually in it?'' She says this trend helps Zingibeer which is vegan, gluten-, preservative-, and sulphite-free and thus more friendly to people with allergies or dietary choices. Zingibeer is manufactured by JJ's Craft Brewing Company in Limerick, a strategic move Rachel and her father Kevin Byrne made to reduce the company's risk. 'We did look at setting up our own brewery, but when it came down to it we didn't want the risk and stress of it,' Ms Byrne said. In an effort to improve its profit margin, Zingibeer changed distributor and has looked to supply some of its product directly to on-trade customers, pubs and restaurants. That decision has boosted margins to a healthier level. The transition, however, left Zingibeer without any distribution for a number of months. Despite this, revenue at the company still grew. 'We hit €500,000 in revenue last year, that was exciting. I remember thinking, 'That's a good chunk of money'.' Revenue grew by 30 per cent to €660,000 in 2024, and the company is expecting growth of 30 per cent to more than €850,000 this year. Zingibeer's rhinoceros hornbill icon will soon be on the sides of cans, as the company looks to continue to develop its product with younger generations in mind. 'It's not a toucan,' Ms Byrne said in a reference to the use of that bird by Guinness. The company created its branding around the national bird of Malaysia, where it first sourced its ginger. Their ginger beer may have entered a relatively small market, but it is growing and they are competing in Ireland against offerings from two large global brands, Hollows & Fentimans and Crabbies. 'We are definitely second to Hollows & Fentimans in terms of volume, and we're winning in a lot of the on-trade accounts,' she said, but the brand is fighting against companies with a '10-year head start'. Being a domestic brand has helped so far, with bars being 'happy' to offer Zingibeer 'because it's Irish and because people really like it.' Outside of Ireland, the Byrnes have begun working with a Danish distributor to bring its brand to an international audience.
Yahoo
10-05-2025
- Yahoo
Trial date for man accused of weapons violations moved
SMITHFIELD, Va. (WAVY) — The Smithfield man found in possession of more than 150 pipe bombs will not go to trial this month. Brad Spafford, 36, was arrested in December, and when FBI agents searched his property, they found what they described as the largest seizure of finished explosive devices in their history. FBI: Homemade explosives seizure at Isle of Wight farm largest in its history Spafford was charged with a federal weapons violation and a single count of possession of an unregistered explosive device. Spafford's case was originally scheduled to go to trial May 26, but Thursday, District Judge Arenda Wright Allen signed off on a joint motion to continue to a later date. The attorneys in the case say they need more time to go over evidence and are still waiting for lab analysis, according to the filing. The document also mentions discussion of a pre-trial resolution of the matter. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
